Novo Nordisk, Lose Weight and Obesity Drug
Digest more
The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond current GLP-1 medications.
Everyday Health on MSN
Quitting Zepbound Leads to at Least 25 Percent Weight Regain After a Year
Most people who stopped taking their weight loss injections also experienced negative changes in blood pressure, waist size, and other health metrics.
GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the drugs affect the body beyond just weight loss. But one of the more anticipated studies exploring how they impact Alzheimer’s disease has found no meaningful effect, Novo Nordisk said in a press release on Nov. 24
The studies come as more and more women are turning to GLP-1 drugs to help them lose weight, particularly after menopause when hormonal changes can make weight loss more difficult. Now, a growing number of telehealth companies have pitched weight-loss drugs as a solution for women experiencing menopause-related weight gain.
James Jordan explains why gruff Dale Bradley is looking so fit on "Landman" Season 2. Jordan has lost 35 pounds with his health regimen.
The daily pill may provide a more convenient alternative to injections, which patients can find difficult to administer.
The musician took to Substack to share an essay titled, “Why is everybody losing weight and what do we do? Sincerely, a person who’s lost weight.”
Participants lost more weight on a low-fat vegan diet than on the Mediterranean diet, largely due to eliminating animal foods and reducing oils and nuts. Increased intake of plant foods, even “unhealthy” ones,